Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lloydspharmacy trials hub and spoke dispensing model

Lloydspharmacy is trialling a hub and spoke dispensing model in north west England. The multiple has opened a dispensary at AAH’s Warrington depot, its pharmacy director Andy Murdock confirmed.


Pharmacies participating in the trial send scripts to the hub, where the medicines are dispensed and then returned to the pharmacies.


Mr Murdock said: “We’re trying to understand what pharmacists might have to do to create time and space to allow pharmacists and pharmacy teams to be able to deliver the new clinical world.”


Rival Alliance Boots had 13 “central dispensaries”, it reported in its 2007 preliminary results.


RPSGB head of policy and communications David Pruce agreed such models had “potential” to free up pharmacists’ time for clinical services, and called for a wider debate on them.


There was potential for independents to develop similar models, Independent Pharmacy Federation chairman Fin McCaul said, but added: “This will take a lot of co-operation.”

It was unclear from legislation whether pharmacists at hubs or spokes would be responsible for dispensing errors in such models, said Noel Wardle, a solicitor at Charles Russell. But clear SOPs would satisfy spoke pharmacists that accuracy checking had been carried out at the hub.


It would be “unreasonable” and duplicate work if spokes were required to recheck dispensed prescriptions, Mr Wardle added.


Lloydspharmacy was “very comfortable with the processes we have”, Mr Murdock said.


         
Pharmacist Manager
East Kilbride, Glasgow
£45,000 - £55,000

Apply Now
Latest News & Analysis
UsernamePublicRestriction

Register

CD010536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel